These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31088544)

  • 1. Prognostic implications and interaction of L1 methylation and p53 expression statuses in advanced gastric cancer.
    Shin YJ; Kim Y; Wen X; Cho NY; Lee S; Kim WH; Kang GH
    Clin Epigenetics; 2019 May; 11(1):77. PubMed ID: 31088544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation status of long interspersed element-1 in advanced gastric cancer and its prognostic implication.
    Song YS; Kim Y; Cho NY; Yang HK; Kim WH; Kang GH
    Gastric Cancer; 2016 Jan; 19(1):98-106. PubMed ID: 25609453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of L1 methylation and tumor-infiltrating lymphocytes as prognostic marker in advanced gastric cancer.
    Kim Y; Rhee YY; Wen X; Cho NY; Bae JM; Kim WH; Kang GH
    Gastric Cancer; 2020 May; 23(3):464-472. PubMed ID: 31691036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatory low methylation statuses of SAT-α and L1 are associated with shortened survival time in patients with advanced gastric cancer.
    Kim Y; Wen X; Jeong S; Cho NY; Kim WH; Kang GH
    Gastric Cancer; 2019 Jan; 22(1):37-47. PubMed ID: 29926315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
    Cheng LL; Itahana Y; Lei ZD; Chia NY; Wu Y; Yu Y; Zhang SL; Thike AA; Pandey A; Rozen S; Voorhoeve PM; Yu Q; Tan PH; Bay BH; Itahana K; Tan P
    Clin Cancer Res; 2012 Aug; 18(15):4201-12. PubMed ID: 22675170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subtyping of gastric cancer combining genetic and epigenetic anomalies provides distinct clinicopathological features and prognostic impacts.
    Tahara T; Tahara S; Horiguchi N; Okubo M; Terada T; Yamada H; Yoshida D; Omori T; Osaki H; Maeda K; Kamano T; Funasaka K; Nagasaka M; Nakagawa Y; Shibata T; Ohmiya N
    Hum Mutat; 2019 Mar; 40(3):347-354. PubMed ID: 30575210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype.
    Waraya M; Yamashita K; Ema A; Katada N; Kikuchi S; Watanabe M
    PLoS One; 2015; 10(10):e0139902. PubMed ID: 26447864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in males with glioma and gastric adenocarcinoma correlates with mutant p53 residual transcriptional activity.
    Fischer NW; Prodeus A; Gariépy J
    JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune signatures correlate with L1 retrotransposition in gastrointestinal cancers.
    Jung H; Choi JK; Lee EA
    Genome Res; 2018 Aug; 28(8):1136-1146. PubMed ID: 29970450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALU and LINE-1 hypomethylations in multistep gastric carcinogenesis and their prognostic implications.
    Bae JM; Shin SH; Kwon HJ; Park SY; Kook MC; Kim YW; Cho NY; Kim N; Kim TY; Kim D; Kang GH
    Int J Cancer; 2012 Sep; 131(6):1323-31. PubMed ID: 22120154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression.
    Thiem A; Hesbacher S; Kneitz H; di Primio T; Heppt MV; Hermanns HM; Goebeler M; Meierjohann S; Houben R; Schrama D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):397. PubMed ID: 31506076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of angiogenesis-related genes in human gastric cancers with and those without high-frequency microsatellite instability.
    Miyamoto N; Yamamoto H; Taniguchi H; Miyamoto C; Oki M; Adachi Y; Imai K; Shinomura Y
    Cancer Lett; 2007 Aug; 254(1):42-53. PubMed ID: 17374440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level.
    Rhee YY; Kim MJ; Bae JM; Koh JM; Cho NY; Juhnn YS; Kim D; Kang GH
    Ann Surg Oncol; 2012 Oct; 19(11):3441-8. PubMed ID: 22618722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer.
    Pallocca M; Goeman F; De Nicola F; Melucci E; Sperati F; Terrenato I; Pizzuti L; Casini B; Gallo E; Amoreo CA; Vici P; Di Lauro L; Buglioni S; Diodoro MG; Pescarmona E; Mazzotta M; Barba M; Fanciulli M; De Maria R; Ciliberto G; Maugeri-Saccà M
    J Transl Med; 2018 Sep; 16(1):247. PubMed ID: 30180862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter.
    Blackburn J; Roden DL; Ng R; Wu J; Bosman A; Epstein RJ
    Mol Carcinog; 2016 Dec; 55(12):1940-1951. PubMed ID: 26676339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 deregulation in Epstein-Barr virus-associated gastric cancer.
    Ribeiro J; Malta M; Galaghar A; Silva F; Afonso LP; Medeiros R; Sousa H
    Cancer Lett; 2017 Sep; 404():37-43. PubMed ID: 28729047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status.
    Szeliga M; Bogacińska-Karaś M; Kuźmicz K; Rola R; Albrecht J
    Mol Carcinog; 2016 Sep; 55(9):1309-16. PubMed ID: 26258493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53.
    Zhang L; Li W; Cao L; Xu J; Qian Y; Chen H; Zhang Y; Kang W; Gou H; Wong CC; Yu J
    Oncogene; 2019 Jun; 38(23):4590-4604. PubMed ID: 30745575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.